These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1585921)

  • 21. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
    Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D
    Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of IgA2m(2)-K type multiple myeloma consists double precipitin lines].
    Fukushima H; Ebata H; Nouno R; Sakisaka S; Mashiko N; Harada M; Hirai K; Nakashima F; Kubo Y; Shimokawa Y
    Rinsho Ketsueki; 1984 Jul; 25(7):1103-8. PubMed ID: 6438369
    [No Abstract]   [Full Text] [Related]  

  • 23. Anion gap in multiple myeloma.
    Paladini G; Sala PG
    Acta Haematol; 1979; 62(3):148-52. PubMed ID: 118613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytology of myeloma cells.
    Hayhoe FG; Neuman Z
    J Clin Pathol; 1976 Oct; 29(10):916-22. PubMed ID: 824323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multiple myeloma with two serum M components (IgG-lambda, IgA-kappa) and two Bence Jones proteins (lambda, kappa)--evidence for two distinct monoclonal cell populations and effects of chemotherapy and plasmapheresis].
    Wakui H; Nishimura S; Akihama T; Imai H; Takahashi T; Kuwayama A; Nakamoto Y; Miura AB
    Nihon Naika Gakkai Zasshi; 1984 Dec; 73(12):1811-7. PubMed ID: 6442730
    [No Abstract]   [Full Text] [Related]  

  • 26. A unique case of kappa light-chain disease associated with cryoglobulinemia, pyroglobulinemia, and hyperviscosity syndrome.
    Bachrach HJ; Myers JB; Bartholomew WR
    Am J Med; 1989 May; 86(5):596-602. PubMed ID: 2496601
    [No Abstract]   [Full Text] [Related]  

  • 27. Measurement of free kappa and lambda chains in serum and the significance of their ratio in patients with multiple myeloma.
    Nelson M; Brown RD; Gibson J; Joshua DE
    Br J Haematol; 1992 Jun; 81(2):223-30. PubMed ID: 1643019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical manifestations of multiple myeloma: relation to class and type M component.
    Pruzanski W
    Can Med Assoc J; 1976 May; 114(10):896-7. PubMed ID: 817790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paraproteinaemia: use of idiotypic determinants as specific markers for tumour activity.
    King MA; Vivianwells J
    Clin Exp Immunol; 1981 Sep; 45(3):544-51. PubMed ID: 6175454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonsecretory myeloma associated with nodular glomerulosclerosis.
    Sølling K; Sølling J; Jacobsen NO; Thomsen OF
    Acta Med Scand; 1980; 207(1-2):137-43. PubMed ID: 6768224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple myeloma protein with three light chains.
    Sun T; Erichson RB; Lien YY; Wu CH
    Clin Chem; 1982 May; 28(5):1227-30. PubMed ID: 6804124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating monotypic B-cells in multiple myeloma: association with lambda paraproteins.
    Bagg A; Becker P; Bezwoda W; van Rensburg L; Mendelow B
    Br J Haematol; 1989 Jun; 72(2):167-72. PubMed ID: 2503024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple myeloma with an IgD kappa monoclonal protein.
    Ford HC; Casey BR; Walker S; Mason A
    Am J Clin Pathol; 1980 Jul; 74(1):105-7. PubMed ID: 6772017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune complex hyperlipidemia induced by an apolipoprotein-reactive immunoglobulin A paraprotein from a patient with multiple myeloma. Characterization of this immunoglobulin.
    Kilgore LL; Patterson BW; Parenti DM; Fisher WR
    J Clin Invest; 1985 Jul; 76(1):225-32. PubMed ID: 3160725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of IgG (k type) multiple myeloma with coma paraproteinemicum and asterixis--hyperviscosity syndrome (author's transl)].
    Yamada S; Watanabe T; Shibata A; Yuasa T
    Nihon Naika Gakkai Zasshi; 1980 Sep; 69(9):1119-25. PubMed ID: 6776206
    [No Abstract]   [Full Text] [Related]  

  • 36. Monitoring myeloma: light chain isotype suppression. A new parameter.
    Wearne A; Joshua DE; Kronenberg H
    Aust N Z J Med; 1985 Oct; 15(5):629-33. PubMed ID: 3937514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spurious hyperphosphataemia caused by an IgA paraprotein: a topic revisited.
    Sinclair D; Smith H; Woodhead P
    Ann Clin Biochem; 2004 Mar; 41(Pt 2):119-24. PubMed ID: 15025801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
    Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J
    Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in lymphocyte surface immunoglobulins in myeloma and the effect of an RNA-containing plasma factor.
    Chen Y; Bhoopalam N; Yakulis V; Heller P
    Ann Intern Med; 1975 Nov; 83(5):625-31. PubMed ID: 812401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Monoclonal plasmocytic myeloma with 2 paraproteins, IgG kappa and IgG lambdal].
    Villiamey J; Bouvet JP; Di Menza C; Boccara M
    Nouv Presse Med; 1974 Dec; 3(45):2707-11. PubMed ID: 4142506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.